BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 3, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
Sunitinib/erlotinib improves progression-free survival in NSCLC
Aug. 24, 2010
Banyu Pharma and Merck & Co. present new PKB inhibitors
Aug. 24, 2010
Health Canada conditionally approves Tasigna for CML
Aug. 24, 2010
Meta-analysis reveals potential link between ARBs and onset of cancer
Aug. 23, 2010
University of Pittsburgh receives NCI grant to develop agents for head and neck cancer
Aug. 20, 2010
Celgene receives marketing authorization in Japan for Revlimid
Aug. 20, 2010
SRI International and Taiho furthering development of TAS-108 for breast cancer
Aug. 20, 2010
Combination of first-line bevacizumab and chemotherapy is safe in NSCLC
Aug. 20, 2010
Karus Therapeutics presents new HDAC inhibitors
Aug. 20, 2010
Clavis begins enrollment in phase III trial of elacytarabine in late-stage AML
Aug. 19, 2010
Previous
1
2
…
2633
2634
2635
2636
2637
2638
2639
2640
2641
…
4145
4146
Next
RSS